---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-303307"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2026-07-14T20:48:25+00:00"
generated_at: "2026-07-14T20:50:05.852018+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Palvella posts corporate presentation; no material new disclosures

## Summary
- Filed corporate presentation dated July 2026 under Item 8.01.
- Presentation will be used in investor meetings; no specific financial or pipeline updates provided.
- No earnings, clinical data, or guidance changes included in the filing.

## SEC filing metadata
- accession: 0001193125-26-303307
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2026-07-14T20:48:25+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000119312526303307/0001193125-26-303307-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000119312526303307/pvla-20260714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-303307
- JSON: https://secwatch.observer/filing/0001193125-26-303307.json
- Plain text: https://secwatch.observer/filing/0001193125-26-303307.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.